In a landmark trial, the lawyer of a terminally ill man who says using Monsanto’s ‘Roundup’ weed killer gave him cancer has told the court that the company has bullied scientists and suppressed evidence that the chemical is carcinogenic.
Formerly employed as a school groundskeeper, DeWayne Johnson, the cancer patient who brought this case, is testifying that working with Roundup caused him to develop non-Hodgkin’s lymphoma. Significantly, therefore, while Monsanto denies the carcinogenicity of glyphosate, the key ingredient in its Roundup weed killer, the chemical has already been cited by the World Health Organization’s International Agency for Research on Cancer as being “probably carcinogenic to humans.”
In a study published in 2017, scientists at the Dr. Rath Research Institute further confirmed the damaging effects of glyphosate on cells and described how speciﬁc micronutrients applied in proper combinations and dosages can provide some protective eﬀects against it. Not only was this research essentially ignored, however, evidence has also emerged that Monsanto had seemingly manipulated studies on Roundup to conceal its risks.
With thousands of other plaintiffs having made similar claims against it in state courts in the United States, Monsanto’s recent $63 billion takeover by Bayer seems unlikely to bring an end to its legal problems any time soon.